Abstract
The need for surgery for persistent or recurrent hyperparathyroidism results from incomplete resection of abnormal parathyroid glands or adenoma of the remaining gland 6 months after successful surgery. Secondary surgeries can cause major problems, such as healthcare costs and surgical complications, some of which can be disastrous. Preventive medicine is one of the most effective ways to avoid these problems. In this study, our aim is to determine the main causes of persistent hyperparathyroidism and recurrent hyperparathyroidism and prevent these secondary surgeries. We reviewed data of patients who had been reoperated on for persistent hyperparathyroidism and recurrent hyperparathyroidism between July 2015 and November 2018 in our clinic. Patients who underwent reoperation for other reasons, patients under 18 years of age, and patients with missing follow-up information were excluded from the study. Thirty-six patients (7 man and 29 women) were included in the study, and the mean age was 56 SD15.2 years. Thirty of them suffered from persistent hyperparathyroidism, and six (16.7%) of them suffered from recurrent hyperparathyroidism. Ultrasonography was used for localization, which was performed by the department of endocrinology, or, alternatively, radiology, technetium 99m-sestamibi scintigraphy, computer tomography, and magnetic resonance imaging were used. Single imaging modality was used for 19 (52.7%) patients, while more than one imaging modality was used for 17 (47.2%) patients. In the first surgery, 21 (58.3%) patients underwent focus parathyroidectomy, while 15 (41.7%) patients underwent conventional bilateral neck exploration parathyroidectomy. In 29 persistent hyperparathyroidism patients, the causes of persistent hyperparathyroidism were pre-op imaging in 18 (62.0%) patients, inexperience of surgeon in 6 (20.6%) patients, and ectopic localization of parathyroid adenoma in 5 (17.4%) patients. Success was achieved in 35 (97.2%) patients after a second surgery, while 1 (2.8%) persistent hyperparathyroidism patient was followed up with medical treatment because no pathological parathyroid adenoma was detected in the imaging studies or in the second exploration. Hyperparathyroidism can persist after a first surgery due to localization discordance in pre-op imaging modalities, inadequate surgical experience, and sometimes because parathyroid adenoma cannot be found despite all efforts. In more than 80% of cases, persistent hyperparathyroidism can be prevented with careful pre-op image studies and surgeries performed by experienced surgeons.
Similar content being viewed by others
References
Guerin C, Paladino NC, Lowery A, Castinetti F, Taieb D, Sebag F (2017) Persistent and recurrent hyperparathyroidism. Updat Surg 69(2):161–169
Udelsman R (2011) Approach to the patient with persistent or recurrent primary hyperparathyroidism. J Clin Endocrinol Metab 96(10):2950–2958
Yeh MW, Wiseman JE, Chu SD, Ituarte PHG, Liu I-LA, Young KL et al (2011) Population-level predictors of persistent hyperparathyroidism. Surgery. 150(6):1113–1119
Venkat R, Kouniavsky G, Tufano RP, Schneider EB, Dackiw APB, Zeiger MA (2012) Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy. World J Surg 36(1):55–60
Karakas E, Müller HH, Schlosshauer T, Rothmund M, Bartsch DK (2013) Reoperations for primary hyperparathyroidism improvement of outcome over two decades. Langenbeck's Arch Surg 398(1):99–106
Henry JF, Sebag F, Cherenko M, Ippolito G, Taieb D, Vaillant J (2008) Endoscopic parathyroidectomy: why and when? World J Surg 32:2509–2515
Henry JF (2010) Reoperation for primary hyperparathyroidism: tips and tricks. Langenbeck's Arch Surg 395:103–109
Shen W, Duren M, Morita E, Higgins C, Duh QY, Siperstein AE et al (1996) Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg 131:861–869
Levin KE, Clark OH (1989) The reasons for failure in parathyroid operations. Arch Surg 124:911–915
Carty SE, Norton JA (1991) Management of patients with persistent or recurrent primary hyperparathyroidism. World J Surg 15:716–723
Grant CS, Thompson G, Farley D, van Heerden J (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140(5):472–479
Nawrot I, Chudzinski W, Ciacka T, Barczynski M, Szmidt J (2014) Reoperations for persistent or recurrent primary hyperparathyroidism: results of a retrospective cohort study at a tertiary referral center. Med Sci Monit 20:1604–1612
Udelsman R, Aruny JE, Donovan PI, Sokoll LJ, Santos F, Donabedian R, Venbrux AC (2003) Rapid parathyroid hormone analysis during venous localization. Ann Surg 237:714–721
Pappu S, Donovan P, Cheng D, Udelsman R (2005) Sestamibi scans are not all created equally. Arch Surg 140:383–386
Hessman O, Stalberg P, Sundin A, Garske U, Rudberg C, Eriksson LG et al (2008) High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 32(5):774–781
Hiramitsu T, Tomosugi T, Okada M, Futamura K, Tsujita M, Goto N et al (2019) Pre-operative localization of the parathyroid glands in secondary hyperparathyroidism: a retrospective cohort study. Sci Rep 9:14634
Toriie S, Sugimoto T, Hokimoto N, Funakoshi T, Ogawa M, Oki T et al (2016) Evaluation of the minimally invasive parathyroidectomy in patients with primary hyperparathyroidism: a retrospective cohort study. Ann Med Surg (Lond) 0.7:42–47
Shin JJ, Milas M, Mitchell J, Berber E, Ross L, Siperstein A (2011) Impact of localization studies and clinical scenario in patients with hyperparathyroidism being evaluated for re-operative neck surgery. Arch Surg 146(12):1397–1403
Feingold DL, Alexander HR, Chen CC, Libutti SK, Shawker TH, Simonds WF, Marx SJ, Skarulis MC, Doppman JL, Schrump DS, Bartlett DL (2000) Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas. Surgery. 128(6):1103–1110
Wang CA (1977) Parathyroid re-exploration, a clinical and pathological study of 112 cases. Ann Surg 186:140–145
Lee S, Ryu H, Morris LF, Grubbs EG, Lee JE, Harun N, Feng L, Perrier ND (2014) Operative failure in minimally invasive parathyroidectomy utilizing an intraoperative parathyroid hormone assay. Ann Surg Oncol 21(6):1878–1883
Singh Ospina NM, Rodriguez-Gutierrez R, Maraka S, Espinosa de Ycaza AE, Jasim S, Castaneda-Guarderas A, Gionfriddo MR, al Nofal A, Brito JP, Erwin P, Richards M, Wermers R, Montori VM (2016) Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis. World J Surg 40(10):2359–2377
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Informed Consent
For this type of study, formal consent is not required.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Toktas, O. Persistent Hyperparathyroidism: How Many Cases Can Be Prevented. Indian J Surg 83, 284–288 (2021). https://doi.org/10.1007/s12262-021-02742-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-021-02742-0